v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investment strategies (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Abbott Laboratories Stock Retirement Plan    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value $ 17,659,748 $ 15,576,603
Abbott Laboratories Stock Retirement Plan | Measured at NAV    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value 11,518,886 9,985,925
Abbott Laboratories Stock Retirement Plan | Collective trust funds    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value 11,120,673 9,592,890
Abbott Laboratories Stock Retirement Plan | Collective trust funds | Measured at NAV    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value 11,120,673 9,592,890
Abbott Laboratories Stock Retirement Plan | Private 40-Act mutual funds    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value 398,213 393,035
Abbott Laboratories Stock Retirement Plan | Private 40-Act mutual funds | Measured at NAV    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value 398,213 393,035
Abbott Laboratories Stock Retirement Plan | Funds filing as direct filing entity | Collective trust funds | Measured at NAV    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value $ 11,120,673 $ 9,592,890
Abbott Laboratories Stock Retirement Plan | Funds filing as direct filing entity | Collective trust funds | Minimum    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Redemption notice period 0 days 0 days
Abbott Laboratories Stock Retirement Plan | Funds filing as direct filing entity | Collective trust funds | Maximum    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Redemption notice period 5 days 5 days
Abbott Laboratories Stock Retirement Plan | Funds not filing as direct filing entity | Short-term fixed income | Measured at NAV    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value $ 398,213 $ 393,035
Abbott Laboratories Stock Retirement Plan (Puerto Rico)    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value 264,892 237,222
Abbott Laboratories Stock Retirement Plan (Puerto Rico) | Measured at NAV    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value 105,489 92,029
Abbott Laboratories Stock Retirement Plan (Puerto Rico) | Collective trust funds    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value 105,489 92,029
Abbott Laboratories Stock Retirement Plan (Puerto Rico) | Collective trust funds | Measured at NAV    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value 105,489 92,029
Abbott Laboratories Stock Retirement Plan (Puerto Rico) | Funds filing as direct filing entity | Collective trust funds | Measured at NAV    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Investments, at fair value $ 105,489 $ 92,029
Abbott Laboratories Stock Retirement Plan (Puerto Rico) | Funds filing as direct filing entity | Collective trust funds | Minimum | Measured at NAV    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Redemption notice period 0 days 0 days
Abbott Laboratories Stock Retirement Plan (Puerto Rico) | Funds filing as direct filing entity | Collective trust funds | Maximum | Measured at NAV    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Redemption notice period 5 days 5 days